Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease.

George S, Rey NL, Tyson T, Esquibel C, Meyerdirk L, Schulz E, Pierce S, Burmeister AR, Madaj Z, Steiner JA, Escobar Galvis ML, Brundin L, Brundin P.

Mol Neurodegener. 2019 Aug 16;14(1):34. doi: 10.1186/s13024-019-0335-3.

2.

Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy.

Chatterjee D, Sanchez DS, Quansah E, Rey NL, George S, Becker K, Madaj Z, Steiner JA, Ma J, Escobar Galvis ML, Kordower JH, Brundin P.

J Parkinsons Dis. 2019;9(2):315-326. doi: 10.3233/JPD-191590.

3.

Metabolomic Profiling of Bile Acids in an Experimental Model of Prodromal Parkinson's Disease.

Graham SF, Rey NL, Ugur Z, Yilmaz A, Sherman E, Maddens M, Bahado-Singh RO, Becker K, Schulz E, Meyerdirk LK, Steiner JA, Ma J, Brundin P.

Metabolites. 2018 Oct 31;8(4). pii: E71. doi: 10.3390/metabo8040071.

4.

Biochemical Profiling of the Brain and Blood Metabolome in a Mouse Model of Prodromal Parkinson's Disease Reveals Distinct Metabolic Profiles.

Graham SF, Rey NL, Yilmaz A, Kumar P, Madaj Z, Maddens M, Bahado-Singh RO, Becker K, Schulz E, Meyerdirk LK, Steiner JA, Ma J, Brundin P.

J Proteome Res. 2018 Jul 6;17(7):2460-2469. doi: 10.1021/acs.jproteome.8b00224. Epub 2018 May 25.

5.

The concept of alpha-synuclein as a prion-like protein: ten years after.

Steiner JA, Quansah E, Brundin P.

Cell Tissue Res. 2018 Jul;373(1):161-173. doi: 10.1007/s00441-018-2814-1. Epub 2018 Feb 26. Review.

6.

Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term.

Rey NL, George S, Steiner JA, Madaj Z, Luk KC, Trojanowski JQ, Lee VM, Brundin P.

Acta Neuropathol. 2018 Jan;135(1):65-83. doi: 10.1007/s00401-017-1792-9. Epub 2017 Dec 5.

7.

Patient-specific in silico models can quantify primary implant stability in elderly human bone.

Steiner JA, Hofmann UAT, Christen P, Favre JM, Ferguson SJ, van Lenthe GH.

J Orthop Res. 2018 Mar;36(3):954-962. doi: 10.1002/jor.23721. Epub 2017 Sep 20.

8.

A novel in silico method to quantify primary stability of screws in trabecular bone.

Steiner JA, Christen P, Affentranger R, Ferguson SJ, van Lenthe GH.

J Orthop Res. 2017 Nov;35(11):2415-2424. doi: 10.1002/jor.23551. Epub 2017 Mar 8.

9.

Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease.

Ghosh A, Tyson T, George S, Hildebrandt EN, Steiner JA, Madaj Z, Schulz E, Machiela E, McDonald WG, Escobar Galvis ML, Kordower JH, Van Raamsdonk JM, Colca JR, Brundin P.

Sci Transl Med. 2016 Dec 7;8(368):368ra174.

PMID:
27928028
10.

Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's disease.

Rey NL, Steiner JA, Maroof N, Luk KC, Madaj Z, Trojanowski JQ, Lee VM, Brundin P.

J Exp Med. 2016 Aug 22;213(9):1759-78. doi: 10.1084/jem.20160368. Epub 2016 Aug 8.

11.

Screw insertion in trabecular bone causes peri-implant bone damage.

Steiner JA, Ferguson SJ, van Lenthe GH.

Med Eng Phys. 2016 Apr;38(4):417-22. doi: 10.1016/j.medengphy.2016.01.006. Epub 2016 Feb 23.

PMID:
26920074
12.

Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology.

Tyson T, Steiner JA, Brundin P.

J Neurochem. 2016 Oct;139 Suppl 1:275-289. doi: 10.1111/jnc.13449. Epub 2016 Feb 10. Review.

13.

Computational analysis of primary implant stability in trabecular bone.

Steiner JA, Ferguson SJ, van Lenthe GH.

J Biomech. 2015 Mar 18;48(5):807-15. doi: 10.1016/j.jbiomech.2014.12.008. Epub 2014 Dec 29. Review.

PMID:
25579993
14.

Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.

Nordströma U, Beauvais G, Ghosh A, Pulikkaparambil Sasidharan BC, Lundblad M, Fuchs J, Joshi RL, Lipton JW, Roholt A, Medicetty S, Feinstein TN, Steiner JA, Escobar Galvis ML, Prochiantz A, Brundin P.

Neurobiol Dis. 2015 Jan;73:70-82. doi: 10.1016/j.nbd.2014.09.012. Epub 2014 Oct 2.

15.

α-Synuclein: the long distance runner.

George S, Rey NL, Reichenbach N, Steiner JA, Brundin P.

Brain Pathol. 2013 May;23(3):350-7. doi: 10.1111/bpa.12046. Review.

16.

Mind the gut: secretion of α-synuclein by enteric neurons.

Grathwohl SA, Steiner JA, Britschgi M, Brundin P.

J Neurochem. 2013 May;125(4):487-90. doi: 10.1111/jnc.12191. Epub 2013 Mar 1. No abstract available.

17.

Alpha-synuclein cell-to-cell transfer and seeding in grafted dopaminergic neurons in vivo.

Angot E, Steiner JA, Lema Tomé CM, Ekström P, Mattsson B, Björklund A, Brundin P.

PLoS One. 2012;7(6):e39465. doi: 10.1371/journal.pone.0039465. Epub 2012 Jun 21.

18.

The different contributions of cortical and trabecular bone to implant anchorage in a human vertebra.

Ruffoni D, Wirth AJ, Steiner JA, Parkinson IH, Müller R, van Lenthe GH.

Bone. 2012 Mar;50(3):733-8. doi: 10.1016/j.bone.2011.11.027. Epub 2011 Dec 10.

PMID:
22178777
19.

Can Parkinson's disease pathology be propagated from one neuron to another?

Dunning CJ, Reyes JF, Steiner JA, Brundin P.

Prog Neurobiol. 2012 May;97(2):205-19. doi: 10.1016/j.pneurobio.2011.11.003. Epub 2011 Nov 18. Review.

PMID:
22115849
20.

A deadly spread: cellular mechanisms of α-synuclein transfer.

Steiner JA, Angot E, Brundin P.

Cell Death Differ. 2011 Sep;18(9):1425-33. doi: 10.1038/cdd.2011.53. Epub 2011 May 13. Review.

21.

α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells.

Hansen C, Angot E, Bergström AL, Steiner JA, Pieri L, Paul G, Outeiro TF, Melki R, Kallunki P, Fog K, Li JY, Brundin P.

J Clin Invest. 2011 Feb;121(2):715-25. doi: 10.1172/JCI43366. Epub 2011 Jan 18.

22.

Are synucleinopathies prion-like disorders?

Angot E, Steiner JA, Hansen C, Li JY, Brundin P.

Lancet Neurol. 2010 Nov;9(11):1128-38. doi: 10.1016/S1474-4422(10)70213-1. Epub 2010 Sep 16. Review.

PMID:
20846907
23.

Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouse.

Veenstra-Vanderweele J, Jessen TN, Thompson BJ, Carter M, Prasad HC, Steiner JA, Sutcliffe JS, Blakely RD.

J Neurodev Disord. 2009 Jun;1(2):158-71. doi: 10.1007/s11689-009-9020-0.

24.

cGMP-dependent protein kinase Ialpha associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake.

Steiner JA, Carneiro AM, Wright J, Matthies HJ, Prasad HC, Nicki CK, Dostmann WR, Buchanan CC, Corbin JD, Francis SH, Blakely RD.

Mol Brain. 2009 Aug 5;2:26. doi: 10.1186/1756-6606-2-26.

25.

Enhanced activity of human serotonin transporter variants associated with autism.

Prasad HC, Steiner JA, Sutcliffe JS, Blakely RD.

Philos Trans R Soc Lond B Biol Sci. 2009 Jan 27;364(1514):163-73. doi: 10.1098/rstb.2008.0143.

26.

Going with the flow: trafficking-dependent and -independent regulation of serotonin transport.

Steiner JA, Carneiro AM, Blakely RD.

Traffic. 2008 Sep;9(9):1393-402. doi: 10.1111/j.1600-0854.2008.00757.x. Epub 2008 Apr 28. Review.

27.

Rapid stimulation of presynaptic serotonin transport by A(3) adenosine receptors.

Zhu CB, Steiner JA, Munn JL, Daws LC, Hewlett WA, Blakely RD.

J Pharmacol Exp Ther. 2007 Jul;322(1):332-40. Epub 2007 Apr 25.

PMID:
17460150
28.

Disposition of bemitradine, a renal vasodilator and diuretic, in man.

Walls CM, Gray A, Vose CW, Robinson Y, Lopez N, Brownsill RD, Steiner JA.

Xenobiotica. 1988 Dec;18(12):1413-23.

PMID:
3245233
29.

Single- and multiple-dose pharmacokinetics of nufenoxole in healthy human subjects.

Brownsill RD, Hiley MP, Vose CW, Steiner JA, Stafford JE, McAllister A, Rose DA, Gerry N.

Xenobiotica. 1987 Nov;17(11):1373-7.

PMID:
3433806
30.

Disposition of 3H-enisoprost, a gastric antisecretory prostaglandin, in healthy humans.

Allan LM, Hawkins AJ, Vose CW, Firth J, Brownsill RD, Steiner JA.

Xenobiotica. 1987 Oct;17(10):1233-46.

PMID:
3424870
32.

Misoprostol clinical pharmacology. Establishment of activity in man.

Steiner JA.

Dig Dis Sci. 1985 Nov;30(11 Suppl):136S-141S.

PMID:
3932046
33.

Colon cancer screening in a large, multispecialty group practice.

Hatfield AK, Bozinovich MA, Steiner JA, Alster JM, Imrey PB.

Prog Clin Biol Res. 1984;156:283-94. No abstract available.

PMID:
6473437
34.

Efficacy of clonidine in treatment of alcohol withdrawal state.

Wilkins AJ, Jenkins WJ, Steiner JA.

Psychopharmacology (Berl). 1983;81(1):78-80.

PMID:
6415735
35.

Effect of beta-adrenoceptor antagonists on prevalence of peripheral vascular symptoms in hypertensive patients.

Steiner JA, Cooper R, McPherson K, Riley AJ.

Br J Clin Pharmacol. 1982 Dec;14(6):833-7.

36.

Pharmacokinetics of lidocaine and its deethylated metabolite: dose and time dependency studies in man.

Bennett PN, Aarons LJ, Bending MR, Steiner JA, Rowland M.

J Pharmacokinet Biopharm. 1982 Jun;10(3):265-81.

PMID:
7175699
37.
39.

The effect of repeated electroconvulsive shock on corticosterone responses to centrally acting pharmacological stimuli in the male rat.

Steiner JA, Grahame-Smith DG.

Psychopharmacology (Berl). 1980;71(3):205-12. No abstract available.

PMID:
6779331
41.

Pharmacological control of corticosterone secretion in the intact rat [proceedings].

Steiner JA, Grahame-Smith DG.

Br J Pharmacol. 1979 Nov;67(3):489P-490P. No abstract available.

42.

Vascular symptoms in patients with primary Raynaud's phenomenon are not exacerbated by propranolol or labetalol.

Steiner JA, Cooper R, Gear JS, Ledingham JG.

Br J Clin Pharmacol. 1979 Apr;7(4):401-3. No abstract available.

43.

A comparison of propranolol and compound RO3-4787 in the treatment of arterial hypertension in man.

George CF, Lewis PJ, Steiner JA, Dollery CT.

Clin Sci Mol Med Suppl. 1975 Jun;2:65s-67s.

PMID:
802644
44.

L-dopa and the Shy-Drager syndrome.

Steiner JA, Low PA, Huang CY, West M, Uther JB, Allsop JL, Chalmers JP.

Med J Aust. 1974 Jul 27;2(4):133-6. No abstract available.

PMID:
4423292
45.

Histiocytic medullary reticulosis appearing as acute hepatic necrosis.

Steiner JA, Perkins KW, McGovern VJ.

Med J Aust. 1973 Sep 8;2(10):496-8. No abstract available.

PMID:
4750545

Supplemental Content

Loading ...
Support Center